» Authors » Jean-Michel Vignaud

Jean-Michel Vignaud

Explore the profile of Jean-Michel Vignaud including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 80
Citations 1156
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Yguel C, Clauzon D, Lacomme S, Siat J, Lomazzi S, Lardenois E, et al.
Ann Pathol . 2019 Feb; 39(2):87-99. PMID: 30736988
Introduction: PELICAN (« Partager Éfficacement en Laboratoire les Informations des Comptes rendus ANatomopathologiques ») is a software which generates standardized reports and, in parallel, allows to automatically create a database...
12.
Vogin G, Hettal L, Vignaud J, Dartigues P, Goere D, Ferron G, et al.
Ann Surg Oncol . 2019 Jan; 26(3):852-860. PMID: 30635798
Background: Well-differentiated papillary mesothelioma of the peritoneum (WDPMP) is a rare entity. Questions regarding management are still being debated as no more than 50 cases have been reported in the...
13.
Russel A, Nguyen D, Vigouroux C, Gallet P, Vignaud J, Rumeau C, et al.
Head Neck . 2018 Jun; 40(11):2389-2398. PMID: 29947068
Background: The purpose of this study was to describe the pathology of the different compartments in endoscopic resection of nasal intestinal-type adenocarcinomas (ITACs) and its relationships with oncologic outcomes. Methods:...
14.
Brindel A, Huet D, Vaillant P, Vignaud J, Tiotiu A
Bull Cancer . 2018 May; 105(6):549-551. PMID: 29706357
No abstract available.
15.
Clement-Duchene C, Luc A, Casse J, Vignaud J, Lacomme S, Anne V, et al.
Ann Surg Oncol . 2018 Feb; 25(5):1262-1268. PMID: 29450750
Background: The prognosis of lung cancer remains poor; only 20% of patients can undergo surgery. N2 non-small cell lung cancer (NSCLC) is a heterogeneous disease. We conducted a retrospective study...
16.
Renaud S, Seitlinger J, Guerrera F, Reeb J, Beau-Faller M, Voegeli A, et al.
Ann Surg Oncol . 2018 Jan; 25(4):1069-1078. PMID: 29362963
Background: The prognostic value of exon 19 and 21 EGFR mutations in stage IV non-small cell lung cancer (NSCLC) is well established. Objective: We aimed to evaluate the prognostic value...
17.
Humbert A, Lecoanet G, Moog S, Bouderraoui F, Bresler L, Vignaud J, et al.
Endocrine . 2018 Jan; 59(3):529-537. PMID: 29332161
Purpose: Adrenocortical lesions are characterized through imaging, hormonal and histopathological analysis. Our aim was to compare the radiological features of adrenocortical lesions with their cortisol-secreting status and histopathological Weiss score....
18.
Hotton J, Agopiantz M, Leroux A, Charra-Brunaud C, Marie B, Busby-Venner H, et al.
Virchows Arch . 2017 Dec; 472(4):623-633. PMID: 29243125
Minichromosome maintenance complex component 6 (MCM6) is involved in initiating DNA replication and is upregulated during licensed G0 phase of the cell cycle. This early expression permits its labeling of...
19.
Agopiantz M, Forgez P, Casse J, Lacomme S, Charra-Brunaud C, Clerc-Urmes I, et al.
Virchows Arch . 2017 Aug; 471(4):521-530. PMID: 28836043
The promalignant effects of neurotensin (NTS) are sustained in many solid tumors, including hormone-dependent cancers. As the endometrium is also subjected to hormonal regulation, we evaluated the contribution of NTS...
20.
Marchevsky A, LeStang N, Hiroshima K, Pelosi G, Attanoos R, Churg A, et al.
Hum Pathol . 2017 Aug; 67:160-168. PMID: 28782639
Immunohistochemistry is used to distinguish sarcomatoid malignant mesotheliomas (SMM) from spindle cell and pleomorphic carcinomas (SPC) but there are no guidelines on how to interpret cases that show overlapping or...